RIPK1-expressing murine TAMs supported tumor growth while inhibition of RIPK1 activity in TAMs promoted tumor suppression, and increased sensitivity to PD-1 and ICOS-based immunotherapies in mouse model. The gene discussed is RIPK1; the disease is neoplasm.